Search research articles
Contact Us
Filters
Showing results (81-90 of 124) with videos related to
Page
of 13
Sort By:
Journal of Medical Genetics
|
May 31, 2008
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families
G Bougeard, R Sesboüé, S Baert-Desurmont, et al.
British Journal of Cancer
|
March 7, 2013
Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer
A Brédart, J L Kop, A Depauw, et al.
Cancer Research
|
May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisited
F Eisinger, J Jacquemier, C Charpin, et al.
Familial Cancer
|
September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma
B Buecher, M Gauthier-Villars, L Desjardins, et al.
Disease Markers
|
December 14, 1999
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
D Stoppa-Lyonnet, M Caligo, D Eccles, et al.
Disease Markers
|
December 14, 1999
Cancer genetics services in Europe
S Hodgson, B Milner, I Brown, et al.
Lancet (London, England)
|
December 29, 2000
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group
S A Narod, J S Brunet, P Ghadirian, et al.
Gynecologic Oncology Reports
|
September 20, 2021
Tumor <i>BRCA</i> testing can reveal a high tumor mutational burden related to <i>POLE</i> pathogenic variants
M-C Villy, J Masliah-Planchon, S Melaabi, et al.
American Journal of Medical Genetics
|
October 27, 1998
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer
L Essioux, C Girodet, O Sinilnikova, et al.
Neurogenetics
|
May 15, 2009
Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management
M Anheim, M Fleury, B Monga, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 124) with videos related to
Sort By:
Page
of 13
Journal of Medical Genetics
|
May 31, 2008
Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families
G Bougeard, R Sesboüé, S Baert-Desurmont, et al.
British Journal of Cancer
|
March 7, 2013
Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer
A Brédart, J L Kop, A Depauw, et al.
Cancer Research
|
May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisited
F Eisinger, J Jacquemier, C Charpin, et al.
Familial Cancer
|
September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma
B Buecher, M Gauthier-Villars, L Desjardins, et al.
Disease Markers
|
December 14, 1999
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
D Stoppa-Lyonnet, M Caligo, D Eccles, et al.
Disease Markers
|
December 14, 1999
Cancer genetics services in Europe
S Hodgson, B Milner, I Brown, et al.
Lancet (London, England)
|
December 29, 2000
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group
S A Narod, J S Brunet, P Ghadirian, et al.
Gynecologic Oncology Reports
|
September 20, 2021
Tumor <i>BRCA</i> testing can reveal a high tumor mutational burden related to <i>POLE</i> pathogenic variants
M-C Villy, J Masliah-Planchon, S Melaabi, et al.
American Journal of Medical Genetics
|
October 27, 1998
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer
L Essioux, C Girodet, O Sinilnikova, et al.
Neurogenetics
|
May 15, 2009
Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management
M Anheim, M Fleury, B Monga, et al.
Page
of 13